Chief Medical Officer, Calibr, a division of Scripps Research
Pamela D. Garzone is a respected pharmaceutical executive and currently serves as Chief Medical Officer of Calibr, a division of Scripps Research. In her role as Chief Medical Officer, she leverages drug development expertise in the therapeutic areas of oncology, hematology, immunology, neuroscience, cardiovascular, and infectious disease to strategically guide Calibr to achieve its mission. Prior to joining Calibr, she was Vice President, Group Asset Team Lead at Pfizer, serving on multiple leadership teams in an early oncology clinical research department. She has led and managed preclinical and clinical functional lines such as ADME, toxicology, pharmacology, clinical pharmacology, translational sciences and clinical research. Recognized for her industry and regulatory expertise, she has provided consulting services to countless executives in the area of drug development for over a decade. Garzone taught undergraduate and graduate students in the School of Pharmacy at the University of Pittsburgh, conducting clinical research and actively participating as a member of the University’s faculty senate. Garzone received the Pittsburgh School of Pharmacy Distinguished Alumni Award in 2019.
Garzone has comprehensive experience providing trusted leadership on boards and committees for a variety of organizations, including outstanding achievements as National Sponsorship Chair of Women in BioScience. She has been profiled in Clinical Leader and served as a member of its Advisory Board. She currently is on the scientific advisory board of Temple Therapeutics, a private clinical stage biotechnology company.
Garzone earned a Ph.D. in Clinical Science and M.Sc. in Pharmacy from the University of Pittsburgh and a B.Sc. in Pharmacy from Purdue University. She has also obtained certificates in administration and management and non-profit board governance.